5th Jan 2015 14:30
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the Company).
On 31 December 2014, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2014; calculated using an average price of £13.84 per Ordinary Share and $42.91 per ADS:
Non-Executive Director | Ordinary Shares | No. of ADSs |
Sir Christopher Gent | 6,385.452 |
|
Prof Sir Roy Anderson | 1,003.260 |
|
Dr Stephanie Burns |
| 865.991 |
Stacey Cartwright | 256.043 |
|
Lynn Elsenhans |
| 308.422 |
Judy Lewent |
| 208.239 |
Sir Deryck Maughan |
| 2,181.125 |
Dr Daniel Podolsky |
| 1,577.774 |
Tom de Swaan | 1,389.497 |
|
Jing Ulrich |
| 98.139 |
Hans Wijers | 76.661 |
|
The Company and the Non-Executive Directors were informed of these allocations on 5 January 2015.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
5 January 2015
Related Shares:
Glaxosmithkline